You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
陽普醫療(300030.SZ)收到醫療器械註冊變更文件
格隆匯 12-03 16:52

格隆匯12月3日丨陽普醫療(300030.SZ)公佈,2019年12月3日,公司取得了由廣東省藥品監督管理局頒發的《中華人民共和國醫療器械註冊變更文件(體外診斷試劑)》,具體情況如下:

產品名稱:心臟型脂肪酸結合蛋白測定試劑(乾式免疫熒光定量法)

註冊證編號:粵械注準20182401109

變更內容:

1、包裝規格由“25人份/盒”變更為:“20人份/盒、25人份/盒”;

2、產品儲存條件及有效期增加以下內容:包裝規格為25人份/盒的檢查卡鋁箔袋開封后,應在半小時內使用;包裝規格為20人份/盒開封后載機可穩定24小時。

備註:本文件與“粵械注準20182401109”註冊證共同使用。

審批部門:廣東省藥品監督管理局

批准日期:2019年11月28日

此次註冊變更增加了心臟型脂肪酸結合蛋白測定試劑(乾式免疫熒光定量法)的包裝規格,明確了不同規格產品的儲存條件及有效期,形成了產品系列化、差異化,增加了產品競爭力,有助於增強產品差異化競爭的銷售能力,對公司未來的經營將產生積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account